Insiders · PLRX

Eric Lefebvre

Chief Medical Officer at Pliant Therapeutics, Inc. (PLRX)

Eric Lefebvre has filed 23 insider reports with the SEC since January 2021, as chief Medical Officer at Pliant Therapeutics, Inc. (PLRX) and director at CymaBay Therapeutics, Inc. (CBAY). Eric Lefebvre made no open-market purchases or sales in the last 12 months. The latest filing, on January 27, 2025, reports grant or award at Pliant Therapeutics, Inc. (PLRX).

Filings
23
Companies
2
Bought on market
None
Sold on market
$4.68M

Companies where Eric Lefebvre is an insider

CompanyRoleShares heldBoughtSoldAvg buyPrice nowLast filing
Pliant Therapeutics, Inc. logo
PLRX
Pliant Therapeutics, Inc.
Chief Medical Officer240,224$4.68M$0.5951Jan 27, 2025
CymaBay Therapeutics, Inc. logo
CBAY
CymaBay Therapeutics, Inc.
Directorsince March 2022Mar 22, 2024

Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.

Every filing

Compare Eric Lefebvre with

Other insiders at the same companies

Questions about Eric Lefebvre

What is Eric Lefebvre's role at Pliant Therapeutics, Inc.?
Eric Lefebvre reports to the SEC as chief Medical Officer at Pliant Therapeutics, Inc. (PLRX), according to the latest filing on January 27, 2025. Eric Lefebvre has also filed as director at CymaBay Therapeutics, Inc. (CBAY).
How many shares does Eric Lefebvre own?
After the latest filing that states it, Eric Lefebvre directly owned 240,224 shares of Pliant Therapeutics, Inc. (PLRX). Shares held through trusts, funds or family members are reported separately and are not counted here.
Has Eric Lefebvre bought or sold stock recently?
The most recent open-market sale was on January 17, 2025: sold 18,478 shares of Pliant Therapeutics, Inc. (PLRX) for $207K at an average of $11.20.
How do I get alerts when Eric Lefebvre files?
Follow Eric Lefebvre on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.

From SEC Forms 3, 4, 5 and 144 filed by Eric Lefebvre (SEC CIK 0001614741). Totals count each trade once, skipping amendments whose original is on file, from Jan 27, 2021 on. View on SEC EDGAR · Get this as JSON